T. Rowe Price Associates
AUXL

T. Rowe Price Associates’s AUXILIUM PHARAMCEUTICALS INC AUXL Stock Holding History

T. Rowe Price Associates’s Portfolio AUXL Stock Details AUXL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-140,100
Closed -$4.82M – 2616
2014
Q4 		$4.82M Sell
140,100
-17,500
-11% -$571K ﹤0.01% 1467
2014
Q3 		$4.7M Buy
157,600
+10,300
+7% +$218K ﹤0.01% 1467
2014
Q2 		$2.96M Buy
147,300
+18,200
+14% +$417K ﹤0.01% 1521
2014
Q1 		$3.51M Buy
129,100
+24,200
+23% +$642K ﹤0.01% 1476
2013
Q4 		$2.18M Buy
104,900
+15,900
+18% +$300K ﹤0.01% 1524
2013
Q3 		$1.62M Sell
89,000
-7,000
-7% -$126K ﹤0.01% 1577
2013
Q2 		$1.6M Buy
+96,000
New +$1.53M ﹤0.01% 1560

Other funds holding AUXL

California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return

T. Rowe Price Associates's AUXL Position: Q1 2015 in Review

T. Rowe Price Associates sold out of AUXILIUM PHARAMCEUTICALS INC (AUXL) in Q1 2015, closing a stake of 140,100 shares — an estimated $4.82M sold.

T. Rowe Price Associates first reported a position in AUXL in Q2 2013 and held it in 7 quarters. The position peaked at $4.82M in Q4 2014. 1 fund tracked by Wall St. Rank holds AUXL as of Q1 2015.

  • T. Rowe Price Associates reported no remaining AUXILIUM PHARAMCEUTICALS INC position as of Q1 2015 after selling out during the quarter.
  • T. Rowe Price Associates sold 140,100 AUXILIUM PHARAMCEUTICALS INC shares in Q1 2015, an estimated $4.82M.
  • T. Rowe Price Associates first reported a position in AUXILIUM PHARAMCEUTICALS INC in Q2 2013 and held it in 7 quarters.
  • T. Rowe Price Associates's AUXILIUM PHARAMCEUTICALS INC position peaked at $4.82M in Q4 2014.
  • 1 fund tracked by Wall St. Rank held AUXILIUM PHARAMCEUTICALS INC as of Q1 2015.

Based on T. Rowe Price Associates's 13F filing for Q1 2015, filed 15 May 2015.